Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphatic Vessels | 2 | 2022 | 8 | 0.610 |
Why?
|
| Dependovirus | 3 | 2014 | 38 | 0.450 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 13 | 0.430 |
Why?
|
| Endothelial Cells | 1 | 2014 | 59 | 0.410 |
Why?
|
| Virus Integration | 2 | 2011 | 6 | 0.370 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2011 | 2 | 0.350 |
Why?
|
| Genome, Viral | 1 | 2011 | 9 | 0.350 |
Why?
|
| Viral Proteins | 1 | 2011 | 12 | 0.340 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 231 | 0.310 |
Why?
|
| Cell Nucleolus | 1 | 2009 | 1 | 0.310 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2009 | 1 | 0.310 |
Why?
|
| Telomerase | 1 | 2009 | 8 | 0.300 |
Why?
|
| Carrier Proteins | 1 | 2009 | 89 | 0.290 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 73 | 0.290 |
Why?
|
| Arachnoid | 2 | 2017 | 6 | 0.260 |
Why?
|
| Indigo Carmine | 1 | 2022 | 1 | 0.190 |
Why?
|
| HeLa Cells | 3 | 2011 | 34 | 0.180 |
Why?
|
| Rats | 3 | 2022 | 623 | 0.170 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 19 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2017 | 314 | 0.160 |
Why?
|
| Blotting, Western | 2 | 2011 | 132 | 0.160 |
Why?
|
| Animals | 5 | 2022 | 3301 | 0.150 |
Why?
|
| Genetic Vectors | 3 | 2014 | 55 | 0.130 |
Why?
|
| Biliverdine | 1 | 2017 | 1 | 0.130 |
Why?
|
| Biological Transport, Active | 1 | 2017 | 11 | 0.130 |
Why?
|
| Bilirubin | 1 | 2017 | 10 | 0.130 |
Why?
|
| Blood | 1 | 2017 | 15 | 0.130 |
Why?
|
| Erythrocytes | 1 | 2017 | 17 | 0.130 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 15 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 34 | 0.130 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 38 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2016 | 50 | 0.130 |
Why?
|
| Retroviridae | 1 | 2014 | 5 | 0.110 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 15 | 0.110 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2014 | 11 | 0.110 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2014 | 1 | 0.100 |
Why?
|
| Iduronidase | 1 | 2014 | 2 | 0.100 |
Why?
|
| Apoptosis | 3 | 2022 | 196 | 0.100 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2013 | 6 | 0.100 |
Why?
|
| Hydrocephalus | 1 | 2013 | 14 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 34 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2014 | 83 | 0.100 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Blotting, Southern | 1 | 2011 | 4 | 0.090 |
Why?
|
| DNA Primers | 1 | 2011 | 50 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 114 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2013 | 411 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 85 | 0.080 |
Why?
|
| Pseudouridine | 1 | 2009 | 1 | 0.080 |
Why?
|
| Chromatography, Thin Layer | 1 | 2009 | 4 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 9 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2009 | 60 | 0.080 |
Why?
|
| RNA Interference | 1 | 2009 | 36 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 69 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 131 | 0.070 |
Why?
|
| Mannitol | 2 | 2017 | 11 | 0.060 |
Why?
|
| Humans | 5 | 2014 | 23207 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2022 | 12 | 0.050 |
Why?
|
| Brain | 2 | 2022 | 1241 | 0.050 |
Why?
|
| Diuretics, Osmotic | 1 | 2017 | 3 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2016 | 18 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 31 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 99 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2016 | 24 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 50 | 0.030 |
Why?
|
| Male | 3 | 2017 | 12662 | 0.030 |
Why?
|
| Collagen | 1 | 2016 | 81 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 244 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 77 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 166 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2014 | 7 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 17 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 32 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1264 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 175 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 483 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 569 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 537 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 598 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 11 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 528 | 0.020 |
Why?
|
| Reoperation | 1 | 2013 | 743 | 0.020 |
Why?
|
| Child | 1 | 2013 | 1160 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 1249 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 1884 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 1657 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 2020 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 2993 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 3865 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 6959 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 7660 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 7981 | 0.010 |
Why?
|
| Female | 1 | 2013 | 13147 | 0.010 |
Why?
|